| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/04/2013 | WO2013044890A1 Amino acid sequences for controlling pathogens |
| 04/04/2013 | WO2013044789A1 Low impurity content caspofungin preparation, method for preparing same, and use thereof |
| 04/04/2013 | WO2013044788A1 Low impurity content caspofungin preparation, method for preparing same, and use thereof |
| 04/04/2013 | WO2013044500A1 Use of hepatitis c virus (hcv) immunogenic peptide or its derivatives in prevention or treatment of arthritis |
| 04/04/2013 | WO2013044499A1 Use of hepatitis c virus immunogenic peptide or its derivative in preparing medicine for preventing or treating colitis |
| 04/04/2013 | WO2013044314A1 In vivo synthesis of elastic fiber |
| 04/04/2013 | WO2013023059A3 Methods and compositions for the treatment of autoimmune and inflammatory diseases |
| 04/04/2013 | WO2013021196A3 Oligodendrocyte differentiation |
| 04/04/2013 | WO2013018091A8 Particles for the treatment of neurodegenerative diseases |
| 04/04/2013 | WO2013017650A3 Formulations comprising saccharomyces boulardii and superoxide dismutase for controlling obesity |
| 04/04/2013 | WO2013010998A3 Compositions and methods for immunomodulation |
| 04/04/2013 | WO2013010225A8 Enzymes for degrading organophosphates |
| 04/04/2013 | WO2013009790A3 A heat stable oxygen carrier-containing pharmaceutical composition for different treatment applications |
| 04/04/2013 | WO2013007596A3 Oral treatment of inflammatory bowel disease |
| 04/04/2013 | WO2013006688A3 N-terminal deleted gp120 immunogens |
| 04/04/2013 | WO2013005603A9 Agent for prevention and/or treatment of allergic inflammation in conjunctiva |
| 04/04/2013 | WO2012177903A3 Methods of treating cognitive impairment |
| 04/04/2013 | WO2012177520A3 Oligopeptides and their use for treating infectious diseases |
| 04/04/2013 | WO2012177020A3 Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof |
| 04/04/2013 | WO2012174365A3 Methods for producing pancreatic precursor cells and uses thereof |
| 04/04/2013 | WO2012170452A3 Compositions and methods for treating neurodegenerative diseases |
| 04/04/2013 | WO2012154756A9 Delaying the progression of diabetes |
| 04/04/2013 | WO2012078671A3 Tricalcium phosphate binding peptides and uses thereof |
| 04/04/2013 | WO2012042371A3 Pharmaceutical composition |
| 04/04/2013 | WO2011158016A3 Assay |
| 04/04/2013 | WO2011020115A3 Methods of treating cancer using growth factor retargeted endopeptidases |
| 04/04/2013 | US20130086701 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
| 04/04/2013 | US20130085461 Method for Pre-Debriding Treatment of Non-Viable Skin Tissue and Compositions and System Thereof |
| 04/04/2013 | US20130085322 Process for the synchronization of ovulation for timed breeding without heat detection |
| 04/04/2013 | US20130085321 Process for the Synchronization of Ovulation for Timed Breeding Without Heat Detection |
| 04/04/2013 | US20130085262 Novel surface antigen |
| 04/04/2013 | US20130085109 Methods of cardiovascular patient treatment using substances sufficient to reduce actin depolymerization |
| 04/04/2013 | US20130085107 Treatments for Gastrointestinal Disorders |
| 04/04/2013 | US20130085106 Methods and formulations for oxytocin treatment of substance use, psychiatric and other disorders |
| 04/04/2013 | US20130085103 Novel synergistic pharmaceutical composition for topical applications |
| 04/04/2013 | US20130085102 Prevention of hypoglycemia in diabetes mellitus type 2 patients |
| 04/04/2013 | US20130085101 Long-acting insulin analogue preparations in soluble and crystalline forms |
| 04/04/2013 | US20130085100 New Uses of Oxytocin-Like Molecules and Related Methods |
| 04/04/2013 | US20130085098 Fibroblast growth factor 21 variants |
| 04/04/2013 | US20130085097 Papillomavirus virus-like particle or capsomere formulation and its use as microbicide |
| 04/04/2013 | US20130085096 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 04/04/2013 | US20130084635 Cell Culture Compositions Capable of Producing a VEGF-Binding Fusion Polypeptide |
| 04/04/2013 | US20130084618 Phenolic binding peptides |
| 04/04/2013 | US20130084327 Polynucleotide encoding a trim-cyp polypeptide, compositions thereof, and methods of using same |
| 04/04/2013 | US20130084326 Liposomes for the oral delivery of therapeutic agents |
| 04/04/2013 | US20130084323 Fenestrated hemostatic patch |
| 04/04/2013 | US20130084320 Tissue fusion method using collagenase for repair of soft tissue |
| 04/04/2013 | US20130084319 Broad-spectrum antimicrobial compositions based on combinations of taurolidine and protamine and medical devices containing such compositions |
| 04/04/2013 | US20130084305 Cosmetic, external skin preparation, and medical instrument |
| 04/04/2013 | US20130084292 Antagonists for the Prevention of Treatment of Inflammatory Bowel Disease, and More Particularly of Crohn's Disease |
| 04/04/2013 | US20130084290 Antibodies to Thymic Stromal Lymphopoietin (TSLP) Receptor Molecules and Uses Thereof |
| 04/04/2013 | US20130084278 Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof |
| 04/04/2013 | US20130084275 Methods and Compositions for Reducing Interleukin-4 or Interleukin-13 Signaling |
| 04/04/2013 | US20130084274 Liquid, Aqueous Pharmaceutical Compositions of Factor VII Polypeptides |
| 04/04/2013 | US20130084273 Variant Form of Urate Oxidase and Use Thereof |
| 04/04/2013 | US20130084272 Compositions, kits and methods for nutritional supplementation with twelve carbon chain fatty acids and twelve carbon chain acylglycerols |
| 04/04/2013 | US20130084263 Pharmaceutical kit and method for treating cancer |
| 04/04/2013 | US20130084262 Repairing bruch's membrane with hydrogels |
| 04/04/2013 | US20130084247 Compositions and methods to prevent cancer with cupredoxins |
| 04/04/2013 | US20130084242 Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor |
| 04/04/2013 | CA2850603A1 Compositions and methods for modulating hemostasis |
| 04/04/2013 | CA2850570A1 Methods of treating cancer |
| 04/04/2013 | CA2850520A1 Aromatic-cationic peptides and methods for using same |
| 04/04/2013 | CA2850469A1 Glycosylated polypeptide and pharmaceutical composition containing same |
| 04/04/2013 | CA2850384A1 In vivo synthesis of elastic fiber |
| 04/04/2013 | CA2850052A1 Alisporivr for treatment of hepatis c virus infection |
| 04/04/2013 | CA2849903A1 Combination therapy for chemoresistant cancers |
| 04/04/2013 | CA2849816A1 Composition and methods for the treatment of degenerative retinal conditions |
| 04/04/2013 | CA2849756A1 Broad-spectrum antimicrobial compositions based on combinations of taurolidine and protamine and medical devices containing such compositions |
| 04/04/2013 | CA2849736A1 Improved formulations of recombinant human bile salt-stimulated lipase |
| 04/04/2013 | CA2849040A1 Amino acid sequences for controlling pathogens |
| 04/04/2013 | CA2849033A1 Immunocytokine combination therapy |
| 04/04/2013 | CA2845735A1 Novel peptide derivatives as antibiotics |
| 04/04/2013 | CA2791626A1 Method for pre-debriding treatment of non-viable skin tissue and compositions and system therefor |
| 04/03/2013 | EP2574624A1 GLP-1 compounds |
| 04/03/2013 | EP2574619A2 Soluble fragments of influenza virus PB2 protein capable of binding RNA-cap |
| 04/03/2013 | EP2574346A1 Cytokine-expressing cellular vaccine combinations |
| 04/03/2013 | EP2574336A1 Use of dipeptidylpeptidase inhibitors to regulate glucose metabolism |
| 04/03/2013 | EP2574330A1 Composition for topical application comprising a protein hydrolysate, applicator and use |
| 04/03/2013 | EP2574172A2 Materials and methods for treatment of inflammation |
| 04/03/2013 | CN1989244B Inhibitors of tgf-r signaling for treatment of cns disorders |
| 04/03/2013 | CN1622958B Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto |
| 04/03/2013 | CN1555268B Therapeutic agents comprising pro-apoptotic proteins |
| 04/03/2013 | CN1526018B Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 04/03/2013 | CN103025756A Banana lectins and uses thereof |
| 04/03/2013 | CN103025753A Crystalline ezatiostat hydrochloride ansolvate |
| 04/03/2013 | CN103025355A Stabilised human immunoglobulin composition |
| 04/03/2013 | CN103025352A Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof |
| 04/03/2013 | CN103025348A Delivery of cholesteryl ester to steroidogenic tissues |
| 04/03/2013 | CN103025347A Pharmaceutical compositions |
| 04/03/2013 | CN103025346A Cold treatment |
| 04/03/2013 | CN103025345A TFPI inhibitors and methods of use |
| 04/03/2013 | CN103025344A Novel DNA-binding proteins and uses thereof |
| 04/03/2013 | CN103025343A Sustained-release formulation |
| 04/03/2013 | CN103025342A Comparison of protein samples |
| 04/03/2013 | CN103025341A Insulin-like growth factor 1 receptor binding peptides |
| 04/03/2013 | CN103025319A Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| 04/03/2013 | CN103014015A Gene segment for coding porcine interferon-gamma and application of gene segment |
| 04/03/2013 | CN103014013A PtPLC (protein tyrosine phosphatase-like (proline instead of catalytic arginine), member c) gene of Pacifastin type serine protease inhibitor of portunus trituberculatus and a coding protein and application thereof |
| 04/03/2013 | CN103012596A Endomorphin-derived peptide with blood-brain barrier permeability as well as synthesis and application of endomorphin-derived peptide |